Answers are grounded in this paper and cite their sources.
COVID-19 greatly reshaped the epidemiology of severe acute respiratory infection (SARI), yet long-term shifts in multi-pathogen circulation remain poorly characterized.This study explored temporal patterns of common respiratory pathogens among adult SARI patients before, during, and after the pandemic. A retrospective multi-center observational study was performed across seven sentinel hospitals in Shanghai, China (2019–2023). Hospitalized SARI patients aged ≥ 15 years were tested for 12 respiratory pathogens (22 subtypes) using real-time polymerase chain reaction (RT-PCR). We stratified the study period into pre-pandemic (2019), pandemic (2020–2022), and post-pandemic (2023) phases for comparative analysis. In total, 4738 participants were enrolled. The overall pathogen detection rate decreased from 30.26% in the pre-pandemic period (2019) to 16.50% during the pandemic (2020–2022), then rebounded to 20.07% in the post-pandemic period (2023) ( P <0.001). A novel classification of four distinct temporal trends was established: (1) decline-resurgence for influenza virus (IFV), Mycoplasma pneumoniae ( M. pneumoniae ), Bordetella pertussis ( B. pertussis ), and human bocavirus (HBoV); (2) sustained decline for human parainfluenza virus (HPIV), human coronavirus (HCoV), human adenovirus (HAdV), human rhinovirus/enterovirus (HRV/EV), and Legionella pneumophila ( L. pneumophila ); (3) transient peak for human metapneumovirus (HMPV); (4) continuous increase for respiratory syncytial virus (RSV). IFV, HRV/EV, and HCoV consistently ranked top five across all periods. M. pneumoniae was the dominant pathogen (33.65%) in patients aged 15–44 years. Seasonal peaks of IFV and RSV were substantially reshaped in the post-pandemic period. The co-infection rate was 1.14% (54/4738), with IFV- M. pneumoniae was the most combination (20.37%). Respiratory pathogen circulation patterns changed substantially from 2019 to 2023. Persistent multi-pathogen surveillance is required to guard against single-pathogen outbreaks and concurrent multi-pathogen epidemics.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: